XML 57 R47.htm IDEA: XBRL DOCUMENT v3.5.0.2
Summary of Significant Accounting Policies - Segment Information (Details)
$ in Thousands
3 Months Ended
Sep. 30, 2016
USD ($)
segment
Sep. 30, 2015
USD ($)
Medical Indication Information    
Contract manufacturing revenue $ 5,063  
Total $ 161,559 $ 106,433
Segment information    
Number of reportable segments | segment 1  
Antibiotic    
Medical Indication Information    
Net sales $ 3,780 2,727
Anti Psychosis    
Medical Indication Information    
Net sales 17,320 2,742
Cardiovascular    
Medical Indication Information    
Net sales 12,694 8,303
Central Nervous System    
Medical Indication Information    
Net sales 10,350  
Gallstone    
Medical Indication Information    
Net sales 12,883 19,972
Gastrointestinal    
Medical Indication Information    
Net sales 18,052 76
Glaucoma    
Medical Indication Information    
Net sales 5,783 6,822
Migraine    
Medical Indication Information    
Net sales 7,160 5,542
Muscle Relaxant    
Medical Indication Information    
Net sales 3,532 1,661
Obesity    
Medical Indication Information    
Net sales 835 979
Pain Management    
Medical Indication Information    
Net sales 6,608 8,133
Respiratory    
Medical Indication Information    
Net sales 2,213  
Thyroid Deficiency    
Medical Indication Information    
Net sales 39,838 41,102
Urinary    
Medical Indication Information    
Net sales 5,101 215
Other    
Medical Indication Information    
Net sales $ 10,347 $ 8,159